Treatment of attention-deficit/hyperactivity disorder

Details Treatment of attention-deficit/hyperactivity disorder Treatment of attention-deficit/hyperactivity disorder

1995-01-11

1997-08-19

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

514646, 514651, A61K 920, A61K 31135

Patent

active

056585900

ABSTRACT:
Tomoxetine, a norepinephrine uptake inhibitor, is used to treat attention-deficit/hyperactivity disorder.

REFERENCES:
Green, Wayne H., Child Adolesc. Psychi. Clinics North America, 1, 449-465 (1992), Oct.
Spencer, et al., J. Am. Acad. Child Adolesc. Psychiatry, 32, 205-210 (1993) Jan.
Biederman, et al., J. Am. Acad. Child Adolesc. Psychiatry, 28, 777-784 (1989).
Wilens, et al., J. Am. Acad. Child Adolesc. Psychiatry, 32, 343-349 (1993) Mar.
Biederman, et al., Am. J. Psychiatry, 148, 564-577 (1991) May.
Biederman, et al., Am. J. Psychiatry, 150, 1792-1798 (1993) Dec.
Gehlert, et al., Neuroscience Ltrs., 157, 203-206 (1993).
Wong, et al., J. Pharmacol. Exp. Therap., 222, 61-65 (1982), Jan.
Wong, David T., and Bymaster, Frank P., Research Comm. Chem. Pathol. Pharmacol., 15, 221-231 (1976) Oct.
Fuller, Ray W., and Wong, David T., J. Clin. Psychopharmacol., 7, 6 Suppl., 36S-43S (1987) Dec.
Wong, et al., Neuropsychopharmacology, 8, 23-33 (1993).
Fuller, et al., J. Pharmacol. Exp. Ther., 269, 132-136 (1994).
Gehlert, et al., Neuroscience Lett., 157, 203-206 (1993).
Zerbe, et al., J. Pharmacol Exp. Ther., 232, 139-143 (1985).
Chumpradit, et al., J. Med. Chem., 35, 4492-4497 (1992) Mar.
Oberlender, et al., J. Pharm. Pharmacol., 39, 1055-1056 (1987) May.
Steinberg, et al., Am. J. Psychiatry, 142, 1517-1518 (1985) Dec.
Chouinard, et al., Psychopharmacology, 83, 126-128 (1984).
Chouinard, et al., Psychopharmacol. Bull., 21, 73-76 (1985).
Farid, et al., J. Clin. Pharmacol., 25, 296-301 (1985).
Fuller, et al., Res. Comm. Chem. Pathol. Pharmacol., 41, 169-172 (1983).
Zhang, et al., J. Pharmacol. Exp. Ther., 259, 1088-1093 (1991) Sep.
Springer, et al., J. Urology, 152, 515-519 (1994) Aug.
Terry, et al., J. Pharmacol. Exp. Ther., 270, 1041-1048 (1994).
Johanson, et al., J. Pharmacol. Exp. Ther., 267, 1-8 (1993) Apr.
Keshavarzian, et al., Gastroenterology, 98, 554-560 (1990).
Cusack, et al., Psychopharmacology, 114, 559-565 (1994).
Ryan, Neal D., J. Child Adolesc. Psychopharmacol., 1, 21-31 (1990).
"Imipramine", Physicians' Desk Ref., 1070-1074 (1993).
"Desipramine", Physicians' Desk Ref., 1389-1390 (1993).
"Nortriptyline", Physicians' Desk Ref., 2115-2116 (1993).
"Amitriptyline", Physicians' Desk Ref., 2372-2374 (1993).
"Clomipramine", Physicians' Desk Ref., 671-675 (1993).
"Bupropion", Physicians' Desk Ref., 842-844 (1993).
"Fluoxetine", Physicians' Desk Ref., 877-880 (1994).
"Chlorpromazine", Physicians' Desk Ref., 2327-2330 (1993).
"Clonidine", Physicians' Desk Ref., 612-614 (1994).

Affiliated with

Also associated with

Rating

Treatment of attention-deficit/hyperactivity disorder does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of attention-deficit/hyperactivity disorder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of attention-deficit/hyperactivity disorder will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1102873